<DOC> 
<DOCNO>1101019_business_story_13073100.utf8</DOCNO> 
<TEXT> 
         
The Telegraph - Calcutta (Kolkata) | Business | Emami charts cash course
                                                                                                                           6                                                                                      Emami charts cash course
          OUR SPECIAL CORRESPONDENT                              
	Calcutta, Oct. 18: City-based personal care major Emami has decided to seek shareholders approval to invest up to Rs 5,000 crore in one or more companies in India and abroad, a sign of the company looking at a big-ticket acquisition.         
	The company has moved a special resolution in this regard.        
	The money will be sourced through debt and equity.         
	Emami  at its board meeting on October 15  also decided to raise long-term resources up to Rs 2,000 crore through the issue of securities. Earlier, the company had hinted at raising funds through qualified institutional placement. The promoters  the Agarwal and Goenka families  have 72 per cent equity in Emami. R.S. Agarwal, chairman of Emami, had hinted at diluting his stake to raise cash.        
	The authorised share capital of the company is consequently being increased to Rs 20 crore from Rs 16 crore.        
	Apart from equity, the company has decided to enhance the present borrowing limit of Rs 1,500 crore to Rs 3,000 crore.         
	Emami has so far grown by acquisitions and developing brand through endorsements. The companys most ambitious acquisition was Zandu Pharma. Emami is now bidding for a controlling stake in Paras Pharma.                                                                                                                                       
</TEXT> 
</DOC>